Epilim:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015

◆英語タイトル:Epilim-API Insights, 2015
◆商品コード:DID2015API142
◆発行会社(調査会社):DelveInsight
◆発行日:2015年版(※最新版はお問い合わせください)
◆ページ数:約20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(納品まで約3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名使用)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD1,000 ⇒換算¥113,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規販売代理店です。DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、Epilim医薬品市場について調査・分析し、医薬品の概要、世界販売量予測、作用機序、薬力学的特性、薬物動態学的特性、アメリカ及びヨーロッパでの市販状況、特許情報、世界各地域別APIメーカー分析情報などを以下の構成でお届けいたします。※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。

・医薬品の概要
・世界販売量予測データ
・医薬品の説明
・作用機序(MOA)
・薬力学的特性
・薬物動態学的特性
・市販状況:アメリカ、ヨーロッパ
・特許情報
・特許権及び独占権(Exclusivity)存続期間
・グローバルAPIメーカー:地域別分析
・企業概要
【レポートの概要】

Summary
DelveInsight’s, Epilim-API Insights, 2015,report provides Epilim marketed details and API Manufacturers details across the globe along with the location. DelveInsight’s report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Epilim. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsight’s report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the Epilim Global sales forecasts data till 2016.
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing ‘Process Validation: General Principles and Practices’. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

[Data Sources]
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.


Scope

• A review of the Epilim based on information derived from company and industry-specific sources
• Coverage of the Marketed data of the Epilim on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for drug with location details.
• Patent Expiry Timeline and Exclusivity Details
• Global Forecasted Sales Figure from 2012-2016
• Qualitative and quantitative assessment of market space


【レポートの目次】

Table of Contents

• Drug Overview
• Global Sales Assessment
• Product Description
• Mechanism of Action
• Pharmacodynamic Properties
• Pharmacokinetic Properties
• Marketed Details for the United States
• Marketed Details for the Europe
• Patent Information
• Patent and Exclusivity Expiry Assessment United States (US)
• Patent Numbers and Expiry Details
• Patent Details
• Global API Manufacturers Assessment
• The United States Drug Master File (US DMF)
• The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
• The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
• The Active Pharmaceutical Ingredient (API) Manufacturers by Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
• Generic Players
• Company Profile
• Summary
• Company Financials
• References
• Appendix
• Methodology
• About DelveInsight
• Contact Us
• Disclaimer

List of Tables
• Epilim, Market, Global Sales (in USD), 2015
• Epilim, Description
• Epilim, Marketed Details the United States (US)
• Epilim, Marketed Details the Europe (EU)
• Epilim, Patent/Exclusivity Expiry (Year), 2015
• Epilim, Patent Number Specific Patent Expiry (Year), 2015
• Epilim, Patent Details
• Epilim, the United States Drug Master File (US DMF), 2015
• Epilim, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2015
• Epilim, the API Manufacturers, China, 2015
• Epilim, the API Manufacturers, India, 2015
• Epilim, the API Manufacturers by the US DMF Status, 2015
• Epilim, the API Manufacturers by Region, 2015
• Epilim, the API Manufacturers by Location/Countries, 2015
• Epilim, Generic Players, 2015
• Company Overview, 2015

List of Figures
• Epilim, Market, Global Sales (in million USD), 2015
• Epilim, Global Sales % Change, 2015
• Epilim, Patent/Exclusivity Expiry (Year), 2015
• Epilim, Patent Number Specific Patent Expiry (Year), 2015
• Epilim, the API Manufacturers by the US DMF Status (%), 2015
• Epilim, the API Manufacturers by Region, 2015
• Epilim, the API Manufacturers by Location/Countries, 2015
• Epilim, Generic Players, 2015

★調査レポート[Epilim:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015] (コード:DID2015API142)販売に関する免責事項を必ずご確認ください。
★調査レポート[Epilim:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆